Centene Q1 2026 Earnings EPS Surges 56 Above Estimates as Managed Care Segment Shows Strength TUSK Q1 2026 Earnings Return to Profitability Drives Shares Higher Danaos Corporation Q1 2026 Earnings Slight EPS Miss Despite Solid Operations GT Biopharma Q1 2026 Earnings Wider Loss and No Revenue as Pipeline Progress Remains Uncertain PRTS Q1 2026 Earnings EPS Surprise of 4885 Despite Negative Earnings Dogwood Therapeutics Inc DWTX Q1 2026 Earnings Narrowing Losses Overshadowed by Flat Drug Pipeline IREN Q1 2026 Earnings Massive EPS Miss Weighs on Sentiment ASM Q1 2026 Earnings Earnings Beat Driven by Operational Efficiency and Metal Prices Rigel Pharmaceuticals Q1 2026 Earnings EPS Falls Short of Expectations Gold Fields Q4 2016 Earnings Narrow EPS Miss Sends Shares Down 135 DIBS Q1 2026 Earnings EPS Beats Estimates Stock Rises 337 UZD Q1 2026 Earnings Significant EPS Beat Drives Stock Uptick